Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Arcus Biosciences Inc
(NY:
RCUS
)
16.90
-0.56 (-3.21%)
Official Closing Price
Updated: 7:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Arcus Biosciences Inc
< Previous
1
2
3
4
5
Next >
18 Stocks Moving in Tuesday's Pre-Market Session
April 05, 2022
Gainers System1, Inc. (NYSE: SST) rose 37.5% to $22.70 in pre-market trading as the company reported a 48% year-over-year surge in Q4 sales and issued strong sales forecast....
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 05, 2022
Good morning, investor! It's time to start off another busy day of trading with the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
Recap: Arcus Biosciences Q4 Earnings
February 23, 2022
Arcus Biosciences (NYSE:RCUS) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:10 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Arcus Biosciences's Earnings: A Preview
February 22, 2022
Arcus Biosciences (NYSE:RCUS) is set to give its latest quarterly earnings report on Wednesday, 2022-02-23. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
August 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
88 Biggest Movers From Yesterday
February 25, 2022
Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren recently announced a $12 million private placement. Indonesia Energy Corporation...
Via
Benzinga
Earnings Scheduled For February 23, 2022
February 23, 2022
Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter. • Plymouth Industrial REIT (NYSE:PLYM)...
Via
Benzinga
"Prudent" Biotech Bets
February 20, 2022
Here, we review two recommended biotechnology stocks following the release of their latest earnings reports. Let's take a look.
Via
Talk Markets
Gilead Stock Dives After Two Major Charges Dig Into Fourth-Quarter Earnings
February 01, 2022
Gilead shares toppled after hours on lighter-than-expected fourth-quarter profit.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 04, 2022
Gainers Oncternal Therapeutics (NASDAQ:ONCT
Via
Benzinga
Why Arcus Biosciences Stock Vaulted Higher in November
December 09, 2021
Arcus was one of the few winners in the turbulent biotech space last month.
Via
The Motley Fool
Arcus Stock Rockets To Record As Gilead Unexpectedly Opts Into Cancer Drugs
November 18, 2021
Gilead opted into three programs from a small biotech company, sending shares flying.
Via
Investor's Business Daily
54 Biggest Movers From Yesterday
November 19, 2021
Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Intraday Session
November 18, 2021
Gainers Dicerna Pharmaceuticals (NASDAQ:DRNA) shares moved upwards by 78.87% to $38.06 during Thursday's regular session. As of 12:30 EST, this security is trading at...
Via
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
November 18, 2021
Gainers Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the...
Via
Benzinga
Exposures
Product Safety
Why Are Arcus Biosciences Shares Trading Higher Today?
November 18, 2021
Gilead Sciences Inc (NASDAQ: GILD) has exercised its options to three programs in Arcus Biosciences Inc (NYSE: RCUS) portfolio, including both anti-TIGIT...
Via
Benzinga
Why Arcus Biosciences Stock Is On Fire Today
November 18, 2021
Gilead Sciences has decided to exercise its options for three of the biotech's oncology programs.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 18, 2021
Gainers Dicerna Pharmaceuticals (NASDAQ:DRNA) stock increased by 78.28% to $37.94 during Thursday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
Recap: Arcus Biosciences Q3 Earnings
November 08, 2021
Arcus Biosciences (NYSE:RCUS) reported its Q3 earnings results on Monday, November 8, 2021 at 04:10 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Arcus Surges As Executive Transfer Could Signal Deeper Gilead Partnership
July 20, 2021
An Arcus executive jumped ship for a role at Gilead, but RCUS stock popped Tuesday on expectations for a closer relationship.
Via
Investor's Business Daily
Why Arcus Biosciences' Big Reveal Wasn't Very Exciting
June 25, 2021
No news from Arcus Biosciences is bad news for the company and other industry heavyweights.
Via
The Motley Fool
45 Biggest Movers From Yesterday
June 25, 2021
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares surged 105.3% to close at $3.51 on Thursday after the company announced it has added the ability to manage Instacart Ads...
Via
Benzinga
Earnings Scheduled For November 8, 2021
November 08, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •...
Via
Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Intraday Session
June 24, 2021
Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 27.11% to $4.5 during Thursday's regular session. As of 12:30 EST, this security is trading at a...
Via
Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
June 24, 2021
Gainers Marin Software Incorporated (NASDAQ: MRIN) jumped 58% to $2.70 after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne...
Via
Benzinga
Here's Why Arcus Biosciences Stock Is Rising Today
June 24, 2021
Investors expecting Gilead Sciences to license Arcus Biosciences' lead asset could be in for an unpleasant surprise.
Via
The Motley Fool
Arcus Biosciences Rockets, But Vague Update In Cancer Study Divides Analysts
June 24, 2021
Arcus Biosciences offered a vague update on its lung cancer regimens Wednesday, but RCUS stock rocketed on Thursday.
Via
Investor's Business Daily
Mid-Morning Market Update: Markets Open Higher; Accenture Reports Upbeat Q3 Results
June 24, 2021
Following the market opening Thursday, the Dow traded up 0.76% to 34,130.38 while the NASDAQ rose 0.75% to 14,379.10. The S&P also rose, gaining 0.54% to 4,264.62. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 24, 2021
Gainers Aravive (NASDAQ:ARAV) stock moved upwards by 21.61% to $6.47 during Thursday's pre-market session. The company's market cap stands at $131.9 million. Arcus...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.